{"Insulin copays for seniors rose between 2017 and 2018": "contradicting the claim that expensive insulin went from big dollars to virtual pennies for seniors.", "The recent executive order on insulin would only impact fewer than 20": "of clinics through a program that provides 10% or less of all prescription drugs, indicating that it does not have a widespread effect as claimed.", "The 340B program": "which the claim references, represents less than a fifth of the participating clinics and hospitals nationwide, and less than 2% of all operations that contract with the program. This suggests that the program itself does not dominate the drug marketplace.", "Insulin copays generally rose from 2017 to 2018": "particularly for those on Medicare, contradicting the claim that expensive insulin has become more affordable."}